Literature DB >> 21923739

Antibodies Against Sporothrix schenckii Enhance TNF-α Production and Killing by Macrophages.

D de Lima Franco1, R C Nascimento1, K S Ferreira1, S R Almeida1.   

Abstract

Sporotrichosis is a chronic granulomatous mycosis caused by the dimorphic fungus Sporothrix schenckii. The immunological mechanisms involved in the prevention and control of sporotrichosis suggest that cell-mediated immunity plays an important role in protecting the host against S. schenckii. Nonetheless, recent data strongly support the existence of protective Abs against this pathogenic fungus. In a previous study, we showed that passive Ab therapy led to a significant reduction in the number of colony forming unit in the organs of mice when the MAb was injected before and during S. schenckii infection. The ability of opsonization to enhance macrophage damage to S. schenckii and subsequent cytokine production was investigated in this work. Here we show that the fungicidal characteristics of macrophages are increased when the fungus is phagocytosed in the presence of inactivated serum from mice infected with S. schenckii or mAb anti-gp70. Additionally, we show an increase in the levels of pro-inflammatory cytokines such as TNF-α and IL-1β. This study provides additional support for the importance of antibodies in protecting against S. schenckii and concludes that opsonization is an important process to increase TNF-α production and fungus killing by macrophages in experimental sporotrichosis.
© 2011 The Authors. Scandinavian Journal of Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21923739     DOI: 10.1111/j.1365-3083.2011.02636.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

Review 1.  Molecular Components of the Sporothrix schenckii Complex that Induce Immune Response.

Authors:  Carlos A Alba-Fierro; Armando Pérez-Torres; Conchita Toriello; Yolanda Romo-Lozano; Everardo López-Romero; Estela Ruiz-Baca
Journal:  Curr Microbiol       Date:  2016-04-27       Impact factor: 2.188

2.  Sporothrix globosa melanin inhibits antigenpresentation by macrophages and enhances deep organ dissemination.

Authors:  Yang Song; Lei Yao; Yu Zhen; Yan Cui; Shuxia Zhong; Yuanyuan Liu; Shanshan Li
Journal:  Braz J Microbiol       Date:  2020-08-09       Impact factor: 2.476

3.  Differences in cell morphometry, cell wall topography and gp70 expression correlate with the virulence of Sporothrix brasiliensis clinical isolates.

Authors:  Rafaela A Castro; Paula H Kubitschek-Barreira; Pedro A C Teixeira; Glenda F Sanches; Marcus M Teixeira; Leonardo P Quintella; Sandro R Almeida; Rosane O Costa; Zoilo P Camargo; Maria S S Felipe; Wanderley de Souza; Leila M Lopes-Bezerra
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

4.  Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy.

Authors:  Francesco Ursini; Emilio Russo; Christian Leporini; Marilena Calabria; Caterina Bruno; Cesare Tripolino; Saverio Naty; Rosa Daniela Grembiale
Journal:  Case Rep Rheumatol       Date:  2015-02-10

5.  Recombinant Phage Elicits Protective Immune Response against Systemic S. globosa Infection in Mouse Model.

Authors:  Feng Chen; Rihua Jiang; Yicun Wang; Mingji Zhu; Xu Zhang; Shuai Dong; Hongxi Shi; Li Wang
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

6.  An immunoproteomic approach revealing peptides from Sporothrix brasiliensis that induce a cellular immune response in subcutaneous sporotrichosis.

Authors:  José Roberto Fogaça de Almeida; Grasielle Pereira Jannuzzi; Gilberto Hideo Kaihami; Leandro Carvalho Dantas Breda; Karen Spadari Ferreira; Sandro Rogério de Almeida
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

Review 7.  Immunity and Treatment of Sporotrichosis.

Authors:  Laura Cristina García Carnero; Nancy Edith Lozoya Pérez; Sandra Elizabeth González Hernández; José Ascención Martínez Álvarez
Journal:  J Fungi (Basel)       Date:  2018-08-20

Review 8.  Immunopathogenesis of Human Sporotrichosis: What We Already Know.

Authors:  Fatima Conceição-Silva; Fernanda Nazaré Morgado
Journal:  J Fungi (Basel)       Date:  2018-07-31

9.  Therapeutic monoclonal antibody for sporotrichosis.

Authors:  Sandro R Almeida
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

Review 10.  Current trends to control fungal pathogens: exploiting our knowledge in the host-pathogen interaction.

Authors:  Laura C García-Carnero; Luis A Pérez-García; José A Martínez-Álvarez; Juana E Reyes-Martínez; Héctor M Mora-Montes
Journal:  Infect Drug Resist       Date:  2018-07-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.